Revises certain requirements for prescription of Schedule II controlled dangerous substances via telemedicine and telehealth without in-person examination or review.*
Take action
Record your position on this measure.
Create an account to record your position, submit testimony, or contact your legislator.
Progress
Where this bill stands in the legislative process.
- Introduced
- Passed Senate
- Passed General Assembly
- To Governor
- Became Law
Overview
This bill modifies New Jersey’s regulations regarding the prescription of Schedule II controlled substances via telemedicine and telehealth. It relaxes requirements for in-person examinations, allowing providers to prescribe these medications remotely under certain conditions. Specifically, it removes the requirement for an initial in-person visit for certain patients, such as those undergoing cancer treatment or hospice care, and allows for prescriptions without in-person visits for stimulants prescribed to minors with parental consent. The bill also establishes guidelines for provider licensing, recordkeeping, and patient communication.
Bill text
Read the latest version inline or switch to a previous version.
Document of record
- Version
- Senate Committee Substitute
- Published
- Not published in the source record
This version is published only as a document. Open the viewer to read it here, or download the file.
Sponsors
Official sponsors from legislative records.
3 on record
Primary sponsors
Arguments
Reasons offered for and against this legislation.
Arguments in favor
No arguments in favor have been submitted.
Submit yoursArguments opposed
No arguments opposed have been submitted.
Submit yours